GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lifeline Scientific Inc (LSE:LSI) » Definitions » Research & Development

Lifeline Scientific (LSE:LSI) Research & Development : £0.69 Mil (TTM As of Jun. 2016)


View and export this data going back to . Start your Free Trial

What is Lifeline Scientific Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Lifeline Scientific's Research & Development for the six months ended in Jun. 2016 was £0.26 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2016 was £0.69 Mil.

Lifeline Scientific Research & Development Historical Data

The historical data trend for Lifeline Scientific's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lifeline Scientific Research & Development Chart

Lifeline Scientific Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.53 1.97 1.79 1.66 0.77

Lifeline Scientific Semi-Annual Data
Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.80 0.80 0.33 0.43 0.26

Lifeline Scientific Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2016 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.69 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lifeline Scientific  (LSE:LSI) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Lifeline Scientific Research & Development Related Terms

Thank you for viewing the detailed overview of Lifeline Scientific's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Lifeline Scientific (LSE:LSI) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lifeline Scientific Inc (LSE:LSI) » Definitions » Research & Development
Comparable Companies
XKRX:115480 ROCO:1799 ASX:RSH BKK:BIZ ROCO:6734 XKRX:238120 LSE:POLX IRIX PAVM IVOB LSE:IHC TSXV:TLT OSTO:CLS B TSXV:LXG OSTO:OSSD ROCO:4121 IGNG XKRX:043100 ASX:LBT XPAR:SSI
Traded in Other Exchanges
N/A
Address
Website
http://www.lifeline-scientific.com
Lifeline Scientific Inc was incorporated on October 1, 1998. The Company is in the business of delivering, to targeted medical markets, a portfolio of related proprietary technologies, which include devices, solutions, and protocols designed to maximize the use and availability of organs, tissues, and cells. It serves the kidney transplant market today with its LifePort product line, and also sells solutions to service the broader organ transplant industry. The Company operates in North America, Brazil, China and Rest of World.